Pharmaceutical Development and Regulation
Latest Publications

TOTAL DOCUMENTS

29
(FIVE YEARS 0)

H-INDEX

4
(FIVE YEARS 0)

Published By Springer-Verlag

1175-9046
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Recruitment and Retention Strategies for Clinical Trials in Alzheimer’s Disease

2003 ◽  
Vol 1 (4) ◽  
pp. 269-276 ◽  
Author(s):  
Marwan N. Sabbagh ◽  
Nancy Thompson ◽  
Deborah Tweedy ◽  
Suhair Stipho-Majeed ◽  
Claudia Kawas ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Trials ◽  
Retention Strategies ◽  
Recruitment And Retention

Regulation of Herbal and Homeopathic Medicines

2003 ◽  
Vol 1 (4) ◽  
pp. 245-259
Author(s):  
Colin J. Briggs ◽  
Olga Norrie

Acknowledgement

2003 ◽  
Vol 1 (4) ◽  
pp. 223-223

The New US Federal Privacy Rules and Impact on Research

2003 ◽  
Vol 1 (4) ◽  
pp. 225-230
Author(s):  
Paul W. Radensky

Postmarketing Drug Safety Surveillance

2003 ◽  
Vol 1 (4) ◽  
pp. 231-244 ◽  
Author(s):  
Jasmanda H. Wu ◽  
Man C. Fung ◽  
Kenneth Kwong ◽  
Kenneth Hornbuckle ◽  
Edmundo Muniz
Keyword(s):  
Drug Safety ◽  
Safety Surveillance ◽  
Drug Safety Surveillance

Potential Expanded Use of Pharmacoeconomics and Outcomes Research in China

2003 ◽  
Vol 1 (3) ◽  
pp. 169-177
Author(s):  
Gordon G. Liu ◽  
Chunhui Liu
Keyword(s):  
Outcomes Research

Equity, Access and Economic Evaluation in Rare Diseases

2003 ◽  
Vol 1 (3) ◽  
pp. 151-157 ◽  
Author(s):  
Nick Bosanquet ◽  
Gianfranco Domenighetti ◽  
Ariel Beresniak ◽  
Jean-Paul Auray ◽  
Luca Crivelli ◽  
...  
Keyword(s):  
Economic Evaluation ◽  
Rare Diseases
Load More ...
Sign in / Sign up

Export Citation Format

Share Document